lung cancer drug Keytruda

News

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.